Govt caps prices of cancer drugs, heart condition medicines
The National Pharmaceutical Pricing Authority (NPPA) has capped prices of 51 essential formulations, including those used for the treatment of cancer, pain, heart conditions and skin problems. The regulator is expected to slash prices anywhere between 6% to 53%, reports said. Companies selling their products at prices higher than the new limits will have to reduce prices immediately.